1. آall V, Gomez C, Fernandez-Llimos F. Situation of drug information centers and services in costa rica. Pharm Pract (Granada) 2006;4:1-7.

2. Mononen N, Järvinen R, Hämeen-Anttila K, Airaksinen M, Bonhomme C, Kleme J, et al. A national approach to medicines information research: A systematic review. Res Social Adm Pharm 2018;14:1106-24. [DOI:10.1016/j.sapharm.2018.01.011]

3. Rosenberg JM, Koumis T, Nathan JP, Cicero LA, McGuire H. Current status of pharmacist-operated drug information centers in the United States. Am J Health Syst Pharm 2004;61:2023-32. [DOI:10.1093/ajhp/61.19.2023]

4. Rosenberg JM, Schilit S, Nathan JP, Zerilli T, McGuire H. Update on the status of 89 drug information centers in the United States. Am J Health Syst Pharm 2009;66:1718-22. [DOI:10.2146/ajhp080563]

5. Oder M, Põld K. Estonian Experience on Establishment of a Modern National Poison Information Centre: One-year Profile of Phone Calls in 2012. Asia Pac J Med Toxicol 2013;2:42-7.

6. Almazrou DA, Ali S, Alzhrani JA. Assessment of Queries Received by the Drug Information Center at King Saud Medical City. J Pharm Bioallied Sci 2017;9:246-50. [DOI:10.4103/JPBS.JPBS_166_17]

7. Churi S, Abraham L, Ramesh M, Narahari MG. Evaluation of poison information services provided by a new poison information center. Indian J Pharmacol 2013;45:496-501. [DOI:10.4103/0253-7613.117781]

8. Ponampalam R, Loh CS. Cost Benefits of the Drug and Poison Information Centre in Preventing Unnecessary Hospitalisation: The Singapore Experience. Hong Kong J Emerg Med 2010;17:45. [DOI:10.1177/102490791001700108]

9. Ghane T, Behmanesh Y, Khazei F. Annual Report of Drug and Poison Information in Iran from March 2012 to March 2013. Acta Med Iran 2016;54:525-9.

10. Nikfar S, Abdollahi M, Cheraghali A. Going from strength to strength; a drug and poison information centre. Essent Drugs Monit 2000;28:30-1.

11. Ghane T, Saberi S, Davoodabadi M. Descriptive Analysis of Recorded Phone Calls to Iran Drug and Poison Information Centers during 2011-2012. Asia Pac J Med Toxicol 2013;2:48-51.

12. Iman K, Afsaneh V, Najme T, Nazafarin H-M, Motahare M-B. Performance of Drug and Poison Information Center within a Referral University Hospital in Southwest of Iran. J Pharm Care 2018;5:22-26.

13. Vassilev ZP, Chu AF, Ruck B, Adams EH, Marcus SM. Evaluation of adverse drug reactions reported to a poison control center between 2000 and 2007. Am J Health Syst Pharm 2009;66:481-7. [DOI:10.2146/ajhp080267]

14. Rao PGM, Jimmy B. Assessment and evaluation of drug information services provided in a South Indian teaching hospital. Indian J Pharmacol 2005;37:315. [DOI:10.4103/0253-7613.16856]

15. Shadnia S, Soltaninejad K, Sohrabi F, Rezvani M, Barari B, Abdollahi M. The performance of loghman-hakim drug and poison information center from 2006 to 2008. Iran J Pharm Res 2011;10:647-52.

16. Maruzi A, Sabbaghian-Tousi S, Karimi G, Jabbari R, Elyasi S. A Ten-year Report of Drug and Poison Information Center in Mashhad, Iran 2007-2017. Iran J Pharm Res 2021;20:e124358.

17. Entezari-Maleki T, Taraz M, Javadi MR, Hajimiri MH, Eslami K, Karimzadeh I, et al. A two-year utilization of the pharmacist-operated drug information center in Iran. J Res Pharm Pract 2014;3:117-22. [DOI:10.4103/2279-042X.145368]

18. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-5. [DOI:10.1001/jama.279.15.1200]

19. Riedl MA, Casillas AM. Adverse drug reactions: types and treatment options. Am Fam Physician 2003;68:1781-90.

20. Aung AK, Zubrinich CM, Goh MSY, Snyder B, Tang MJ, Khu CYL, et al. Development and application of adverse drug reactions reports QUality Algorithm (AQUA-12) score: a single-centre quality improvement initiative. Eur J Clin Pharmacol 2023;79:513-22. [DOI:10.1007/s00228-023-03457-9]